A local hospital is using new technology to remove liver cancer without invasive surgery. It’s a word that no one ever wants ...

Dr. Soon-Shiong is hopeful the Saudi Arabian FDA's approval of his cancer therapy drug, Anktiva, will lead to widespread ...

Overall survival is no better for patients diagnosed with NMIBC who progress directly to metastasis.

ImmunityBio, Inc. (NASDAQ:IBRX) is one of the best penny stocks to buy for 2026. On December 16, ImmunityBio, Inc.

Approval of ANKTIVA was granted for BCG-unresponsive non-muscle-invasive bladder cancer (NMIBC) with carcinoma in situ, with ...

STATEN ISLAND, N.Y. — Northwell Staten Island University Hospital (SIUH) has announced the addition of a new, non-invasive treatment for localized prostate cancer, which provides precision in ...

ImmunityBio stock jumps after strong trial updates in bladder cancer and lymphoma, with enrollment ahead of schedule and FDA ...

ImmunityBio’s IBRX QUILT-2.005 trial tops enrollment forecasts; BLA filing targeted by year-end after positive ANKTIVA+BCG ...

We combine affordable thermal cameras with advanced AI to analyse temperature maps of the human body without radiation, ...

Skin cancer is the most commonly diagnosed form of cancer in the United States and, according to the American Cancer ...